Pharsight

Lacer Pharma patents expiration

1. Ertaczo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5135943 LACER PHARMA 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
May, 2014

(9 years ago)

Drugs and Companies using SERTACONAZOLE NITRATE ingredient

Market Authorisation Date: 10 December, 2003

Treatment: Product is approved for the topical treatment of tinea pedis

Dosage: CREAM;TOPICAL

More Information on Dosage

ERTACZO family patents

Family Patents